These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9291349)

  • 1. Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states.
    Brattig N; Nietz C; Hounkpatin S; Lucius R; Seeber F; Pichlmeier U; Pogonka T
    J Infect Dis; 1997 Sep; 176(3):838-42. PubMed ID: 9291349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
    Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).
    Lucius R; Kern A; Seeber F; Pogonka T; Willenbücher J; Taylor HR; Pinder M; Ghalib HW; Schulz-Key H; Soboslay P
    Trop Med Parasitol; 1992 Sep; 43(3):139-45. PubMed ID: 1281926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.
    MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of T and B cell stimulating domains of the immunodominant 33-kDa protein of Onchocerca volvulus (Ov33).
    Pogonka T; Brattig N; Nde PN; Adam R; Seeber F; Zipfel PF; Titanji VP; Lucius R
    Clin Immunol Immunopathol; 1997 Oct; 85(1):56-66. PubMed ID: 9325070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodiagnostic studies on Onchocerca volvulus and Mansonella perstans infections using a recombinant 33 kDa O. volvulus protein (Ov33).
    Tawill SA; Kipp W; Lucius R; Gallin M; Erttmann KD; Büttner DW
    Trans R Soc Trop Med Hyg; 1995; 89(1):51-4. PubMed ID: 7747307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a recombinant T cell and B cell reactive polypeptide of Onchocerca volvulus.
    Seeber F; Brattig N; Soboslay PT; Pogonka T; Lörz A; Strote G; Beck E; Titanji VP; Lucius R
    J Immunol; 1993 Apr; 150(7):2931-44. PubMed ID: 8454865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human immune responses to the cytosolic superoxide dismutase and glutathione S-transferase from Onchocerca volvulus.
    Brattig NW; Henkle-Dührsen KH; Hounkpatin S; Liebau E; Kruppa TF; Zipfel PF
    Trop Med Int Health; 1997 Aug; 2(8):788-98. PubMed ID: 9294549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus.
    Elson LH; Calvopiña M; Paredes W; Araujo E; Bradley JE; Guderian RH; Nutman TB
    J Infect Dis; 1995 Mar; 171(3):652-8. PubMed ID: 7876612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onchocerca volvulus-mediated keratitis: cytokine production by IL-4-deficient mice.
    Pearlman E; Lass JH; Bardenstein DS; Diaconu E; Hazlett FE; Albright J; Higgins AW; Kazura JW
    Exp Parasitol; 1996 Nov; 84(2):274-81. PubMed ID: 8932777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Onchocerca volvulus: differential cellular and humoral responses to a recombinant antigen, OvMBP20/11.
    Bradley JE; Elson L; Tree TI; Stewart G; Guderian R; Calvopiña M; Paredes W; Araujo E; Nutman TB
    J Infect Dis; 1995 Sep; 172(3):831-7. PubMed ID: 7658078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density.
    Brattig NW; Lepping B; Timmann C; Büttner DW; Marfo Y; Hamelmann C; Horstmann RD
    J Infect Dis; 2002 Apr; 185(8):1148-54. PubMed ID: 11930325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.
    Lüder CG; Soboslay PT; Prince AM; Greene BM; Lucius R; Schulz-Key H
    Parasitology; 1993 Jul; 107 ( Pt 1)():87-97. PubMed ID: 8356001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen.
    Plier DA; Awadzi K; Freedman DO
    J Infect Dis; 1996 Aug; 174(2):380-6. PubMed ID: 8699070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.